本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Akoya Biosciences, Inc.

1.09
-0.0150-1.36%
盘后1.090.00000.00%16:05 EDT
成交量:32.61万
成交额:36.20万
市值:5,405.07万
市盈率:-0.97
高:1.20
开:1.11
低:1.06
收:1.10
数据加载中...
2025/04/04

重要事件披露

Form 8-K - Current report
2025/04/04

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/04/04

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/03/18

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/03/17

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/03/17

重要事件披露

Form 8-K - Current report
2025/03/17

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/17

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/04

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/02/25

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/02/25

重要事件披露

Form 8-K - Current report
2025/02/25

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/02/11

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/01/16

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/01/16

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/01/15

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/01/14

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/01/10

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/01/10

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/01/10

重要事件披露

Form 8-K - Current report